搜索
ss
ss
关于普米斯
About Us
p03

PM1032

Biotheus' 4-1BB agonist is a humanized VHH that targets a unique membrane-proximal epitope on 4-1BB situated on the CRD4 domain to maintain agonist activity but in turn reduce toxicity risk. Activation of 4-1BB can improve immune effector function and memory. By pairing with an anti-CLDN18.2 binder, PM1032 activates 4-1BB in CLDN18.2-enriched tumours. Fc function has been depleted to minimize FcR-mediated crosslinking. In preclinical studies, single-agent activity has been observed, and PM1032 may be used to treat CLDN18.2+ solid tumours such as gastric and pancreatic cancer.
p03
Product description
Parameters

Biotheus' 4-1BB agonist is a humanized VHH that targets a unique membrane-proximal epitope on 4-1BB situated on the CRD4 domain to maintain agonist activity but in turn reduce toxicity risk. Activation of 4-1BB can improve immune effector function and memory. By pairing with an anti-CLDN18.2 binder, PM1032 activates 4-1BB in CLDN18.2-enriched tumours. Fc function has been depleted to minimize FcR-mediated crosslinking. In preclinical studies, single-agent activity has been observed, and PM1032 may be used to treat CLDN18.2+ solid tumours such as gastric and pancreatic cancer.

Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table
Previous
There is currently no content to display
Please add data record on website background.
There is currently no content to display
Please add data record on website background.

Copyright © 2022 Biotheus Inc. All Rights Reserved  粤ICP备2021122492号